StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-14 | $17.79 | $17.96 | +0.96% | 0.2M |
| 05-15 | $17.92 | $17.98 | +0.33% | 0.2M |
| 05-18 | $17.89 | $18.04 | +0.84% | 0.1M |
| 05-19 | $17.80 | $17.47 | -1.85% | 0.1M |
| 05-20 | $17.32 | $18.14 | +4.73% | 0.1M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $250.22M | $925.26M | $699.06M | $485.39M |
Operating Income | $13.87M | $37.43M | $33.61M | $32.39M |
Net Income | $7.51M | $10.76M | $12.54M | $19.06M |
EPS (Diluted) | $0.41 | $0.58 | $0.67 | $1.01 |
Total Assets | $738.97M | $742.91M | $726.59M | $734.53M |
Total Liabilities | $144.18M | $156.64M | $145.04M | $148.97M |
Cash & Equivalents | $162.75M | $158.38M | $145.35M | $151.34M |
Free Cash Flow OCF − CapEx | $7.11M | $8.53M | $14.71M | $19.87M |
Shares Outstanding | 18.46M | 18.28M | 18.27M | 18.26M |
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.